Search Results - "Reckless, J"

JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice by Prepared, b

“…[...]people with a family history of premature CVD should be assessed for their cardiovascular risk and then managed appropriately (III) CARDIOVASCULAR RISK…”
Get full text

Pitavastatin by Mukhtar, R Y A, Reid, J, Reckless, J P D

“…The growing number of trials that have highlighted the benefit of intensive lowering of total- and low density lipoprotein (LDL)-cholesterol levels especially…”
Get more information

Evaluation of the Counterweight Programme for obesity management in primary care: a starting point for continuous improvement by Ross, HM, Laws, R, Reckless, J, Lean, M

“…Evaluation for obesity management in primary care is limited, and successful outcomes are from intensive clinical trials in hospital settings. To determine to…”
Get full text

Bivalirudin for the Treatment of ST-Segment Elevation Myocardial Infarction: A NICE Single Technology Appraisal by Simpson, E. L., Fitzgerald, P., Evans, P., Tappenden, P., Kalita, N., Reckless, J. P. D., Bakhai, A.

“…The National Institute for Health and Clinical Excellence (NICE) invited the manufacturer (The Medicines Company) of bivalirudin to submit evidence for its…”
Get full text

Long-term cost-effectiveness of weight management in primary care by Trueman, P, Haynes, S M, Felicity Lyons, G, Louise McCombie, E, McQuigg, M S A, Mongia, S, Noble, P A, Quinn, M F, Ross, H M, Thompson, F, Broom, J I, Laws, R A, Reckless, J P D, Kumar, S, Lean, M E J, Frost, G S, Finer, N, Haslam, D W, Morrison, D, Sloan, B

“…As obesity prevalence and health-care costs increase, Health Care providers must prevent and manage obesity cost-effectively. Using the 2006 NICE obesity…”
Get more information

Lipoproteins and their subfractions in psoriatic arthritis: identification of an atherogenic profile with active joint disease by Jones, S M, Harris, C P D, Lloyd, J, Stirling, C A, Reckless, J P D, McHugh, N J

“…OBJECTIVES (a) To characterise the lipid profile in psoriatic arthritis and investigate whether there are similarities to the dyslipoproteinaemia reported in…”
Get full text

Benefits and risks around glycaemic control in diabetes: where are we now? by Reckless, J, Robinson, A

Get more information

Lipid-altering efficacy of ezetimibe/simvastatin 10/40 mg compared with doubling the statin dose in patients admitted to the hospital for a recent coronary event: the INFORCE study by Reckless, J P D, Henry, P, Pomykaj, T, Lim, S T, Massaad, R, Vandormael, K, Johnson-Levonas, A O, Lis, K, Brudi, P, Allen, C

“…The aim of this study was to investigate the efficacy and safety profile of switching to ezetimibe/simvastatin (Eze/Simva) 10/40 mg compared with doubling the…”
Get more information

Counterweight - counter-cost, counter-loss by Lean, M E J, Reckless, J P D, Finer, N, McCombie, L

Get more information

Dyslipidaemia in Type 2 diabetes: effects of the thiazolidinediones pioglitazone and rosiglitazone by Mukhtar, R., Reckless, J. P. D.

Get full text

Empowering primary care to tackle the obesity epidemic: the Counterweight Programme by McQuigg, M, Brown, J, Broom, J, Laws, R A, Reckless, J P D, Noble, P A, Kumar, S, McCombie, E L, Lean, M E J, Lyons, G F, Frost, G S, Quinn, M F, Barth, J H, Haynes, S M, Finer, N, Ross, H M, Hole, D J

“…Objective: To improve the management of obese adults (18-75 y) in primary care. Design: Cohort study. Settings: UK primary care. Subjects: Obese patients (body…”
Get full text

The effect of high dose atorvastatin therapy on lipids and lipoprotein subfractions in overweight patients with type 2 diabetes by Lawrence, J.M, Reid, J, Taylor, G.J, Stirling, C, Reckless, J.P.D

“…Few data are available on the effects of high dose statin therapy on lipoprotein subfractions in type 2 diabetes. In a double blind randomised…”
Get full text

The pan‐chemokine inhibitor NR58‐3.14.3 abolishes tumour necrosis factor‐α accumulation and leucocyte recruitment induced by lipopolysaccharide in vivo by Reckless, Jill, Tatalick, Lauren M., Grainger, David J.

“…Summary Chemokines participate in the regulation of leucocyte recruitment in a wide variety of inflammatory processes, including host defence and diseases such…”
Get full text

Identification of oligopeptide sequences which inhibit migration induced by a wide range of chemokines by Reckless, J, Grainger, D J

“…We have identified an amino acid sequence, termed peptide 3, corresponding to amino acids 51-62 of the mature human monocyte chemoattractant protein-1 (MCP-1),…”
Get full text

Efficacy of ezetimibe/simvastatin 10/40 mg compared to doubling the dose of low-, medium- and high-potency statin monotherapy in patients with a recent coronary event by Brudi, P, Reckless, J P, Henry, D P, Pomykaj, T, Lim, S T, Massaad, R, Vandormael, K, Johnson-Levonas, A O

“…The aim of the study was to compare the efficacy/safety of doubling the dose of low-, medium- and high-potency statins on lipids/lipoproteins versus…”
Get more information

The Counterweight programme: Prevalence of CVD risk factors by body mass index and the impact of 10% weight change by McQuigg, M, Brown, J.E, Broom, J, Laws, R.A, Reckless, J.P.D, Noble, P.A, Kumar, S, McCombie, E.L, Lean, M.E.J, Lyons, F.G, Frost, G.S, Quinn, M.F, Barth, J.H, Haynes, S.M, Finer, N, Haslam, D.W, Ross, H.M, Hole, D.J, Radziwonik, S

“…Summary Objectives To examine relationships between body mass index (BMI), prevalence of physician-recorded cardiovascular disease (CVD) risk factors in…”
Get full text

Fluvastatin by Lawrence, J M, Reckless, J P D

“…Fluvastatin was the first wholly synthetic statin to the market and is effective in reducing total and low density lipoprotein cholesterol, which translates…”
Get more information

Pioglitazone by Lawrence, J M, Reckless, J P

“…Pioglitazone is a thiazolidinedione. As a PPAR-gamma agonist it alters the expression of a number of genes, resulting in a reduction in insulin resistance…”
Get more information

The effects of insulin on the level and activity of the GLUT4 present in human adipose cells by KOZKA, I. J, CLARK, A. E, RECKLESS, J. P. D, CUSHMAN, S. W, GOULD, G. W, HOLMAN, G. D

“…Human adipose cells are much less responsive to insulin stimulation of glucose transport activity than are rat adipocytes. To assess and characterize this…”
Get full text

Severe deterioration in cognitive function and personality in five patients with long-standing diabetes: a complication of diabetes or a consequence of treatment? by Gold, A E, Deary, I J, Jones, R W, O'Hare, J P, Reckless, J P, Frier, B M

“…Changes in mood, personality, and social function were examined in a group of five Type 1 diabetic patients, aged 50 to 66 years, with duration of diabetes…”
Get more information